Erin Sweet

Dr. Erin Sweet is an Associate Research Scientist at the Bastyr University Research Institute (BURI) within the School of Naturopathic Medicine at Bastyr University in Seattle, WA. Her research focuses on integrative oncology, particularly evaluating how complementary therapies enhance clinical outcomes and quality of life in cancer patients. She holds a Doctorate in Naturopathic Medicine and an MPH in Epidemiology from the University of Washington, demonstrating expertise in both clinical and population health research.

Her education includes a NIH Postdoctoral Fellowship at BURI, an ND Residency at the National University of Natural Medicine, and advanced training in naturopathic oncology. She is one of 14 board-certified naturopathic oncologists in Washington state and affiliated with institutions like Tacoma General Hospital and the RAND Center for Collaborative Research.

Research interests include clinical effectiveness of integrative oncology protocols, epidemiological studies on treatment safety, and improving patient-centered care through evidence-based practices. Methodologies emphasize observational studies and prospective cohort designs. Notable projects include the Canadian/US Integrative Oncology Study (CUSIOS) evaluating advanced cancer care outcomes.

Dr. Sweet’s work has contributed to understanding CAM supplement risks during chemotherapy and the role of patient decision-making in improving quality of life. She collaborates with organizations like the Society for Integrative Oncology to advance interdisciplinary cancer care.